Skip to main content

Halozyme Therapeutic (NQ: HALO )

52.40 +0.34 (+0.65%)
Streaming Delayed Price Updated: 1:12 PM EDT, Jun 25, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
February 12, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 3
Source: SEC/Edgar
December 11, 2011
Form 3
Source: SEC/Edgar
December 11, 2011
Form 4
Source: SEC/Edgar
November 22, 2011
Form 4
Source: SEC/Edgar
November 15, 2011
Form 4
Source: SEC/Edgar
November 14, 2011
Form 4
Source: SEC/Edgar
August 10, 2011
Form 4
Source: SEC/Edgar
August 09, 2011
Form 4
Source: SEC/Edgar
August 09, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 08, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
February 03, 2011
Form 4
Source: SEC/Edgar
February 03, 2011
Form 4
Source: SEC/Edgar
February 03, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.